Feed 4591.T
45
Ribomic Inc.
4591.T · JPX
¥77.00 +2.67% (+¥2.00)
1M +2.74%
Market Cap ¥4.2B
P/E Ratio -
Div. Yield -
ROE 38.38%
Valuation
50 /100
Fair P/S 1,398.72x
P/B 1.48x
P/E N/A
Growth
0 /100
Declining Rev. growth 64.31%
Book val. growth 13.46%
EPS growth N/A
Profitability
0 /100
Weak Gross margin 0.00%
Net margin 38,178.70%
Op. margin 40,237.70%
Quality
0 /100
Poor ROIC 42.53%
ROE 38.38%
ROA 38.48%
Debt
100 /100
Low Debt/Equity 0.00x
Current ratio 21.68x
Int. coverage N/A
Stability
38 /100
Moderate Beta 0.19x
EPS volatility 20.67%
Profitable years 0
Vprašajte StockBota o 4591.T
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Yoshikazu Nakamura
Employees
25
Headquarters
Tokyo
Prihajajoči dogodki
13 AVG.
Earnings
Upcoming earnings report